NIA Impact Advisors’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.21M Buy
46,731
+15,100
+48% +$858K 1.33% 34
2026
Q1
$2.03M Buy
31,631
+999
+3% +$91.1K 0.9% 38
2025
Q4
$3.98M Sell
30,632
-1,243
-4% -$171K 1.34% 31
2025
Q3
$3.43M Buy
31,875
+14,752
+86% +$1.61M 1.12% 38
2025
Q2
$1.58M Sell
17,123
-1,273
-7% -$99.9K 0.55% 58
2025
Q1
$1.63M Sell
18,396
-860
-4% -$74.6K 0.6% 60
2024
Q4
$1.48M Buy
+19,256
New +$1.35M 0.48% 65

Other funds holding WGS

NIA Impact Advisors's WGS Position: Q2 2026 in Review

NIA Impact Advisors increased its GeneDx Holdings (WGS) stake by 48% in Q2 2026, buying an estimated $858K and bringing the position to 46,731 shares worth $3.21M. The position accounts for 1.33% of the portfolio, ranked #34.

NIA Impact Advisors first reported a position in WGS in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.98M in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • NIA Impact Advisors held 46,731 shares of GeneDx Holdings worth $3.21M as of Q2 2026.
  • NIA Impact Advisors bought 15,100 GeneDx Holdings shares in Q2 2026, an estimated $858K.
  • GeneDx Holdings made up 1.33% of NIA Impact Advisors's portfolio in Q2 2026, its #34 holding.
  • NIA Impact Advisors first reported a position in GeneDx Holdings in Q4 2024 and has held it in 7 quarters since.
  • NIA Impact Advisors's GeneDx Holdings position peaked at $3.98M in Q4 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on NIA Impact Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.